Sequencing from large scale to single cell — the new era of biological discovery
)
- Published on: October 21 2025
Rosemary Sinclair Dokos, Chief Product and Marketing Officer at Oxford Nanopore Technologies, shares the latest developments in Oxford Nanopore sequencing, and how these are enabling translational and clinical human genetics communities to deliver improved insights into mechanisms for disease in one integrated analysis.
This talk was originally presented at ASHG 2025.
